Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
about
Cabozantinib for progressive metastatic medullary thyroid cancer: a reviewClinicopathological features of rare BRAF mutations in Korean thyroid cancer patientsIdentification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid CancerMedullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: A case report.Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinomaSynergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cellsExomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.Sorafenib in metastatic MTC - a case report and minireview of the literature.Development and clinical application of an integrative genomic approach to personalized cancer therapyUpregulation of the PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinomaVandetanib for the treatment of thyroid cancer.Pharmacokinetic evaluation of cabozantinib for the treatment of thyroid cancer.Medullary thyroid carcinoma: a 25-year perspective.PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy.Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.High-resolution analysis of alterations in medullary thyroid carcinoma genomes.Putative BRAF activating fusion in a medullary thyroid cancer.Diagnostic and prognostic markers in differentiated thyroid cancer.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.A family presenting with multiple endocrine neoplasia type 2B: A case report.Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma.
P2860
Q26851709-1118F780-ED0B-407F-A6C0-DFD68BD7DEF0Q34029917-0A941CB1-DB9A-4E42-8061-D5A3087F09F7Q35752400-40B26151-5D42-4C8D-B814-769304C5D4DFQ35772255-27CC5D71-A83B-4776-A706-A8B147077724Q36043347-DA445FC6-9226-4782-9FEE-A55BD54050C5Q36057504-C6747DCC-5ED3-44AD-B19C-A3F6A6898878Q36589374-713CAE17-9AE0-48D0-8E82-3CE16CB11D16Q36856527-3E253142-B4E3-4AC6-8C23-96F311E3F785Q36954557-E6C0F8C7-C90C-4A61-AA3A-0006FCBA69BEQ36975457-7C8E6968-74E4-4060-8F45-FB61BC1211C7Q37967112-EC3AC31D-6412-4455-AE3B-91CA91EC8460Q38089099-091BA260-AA15-4429-AFFF-A82589C5A81CQ38171726-88D1C204-F227-49AE-A1BD-3D42CC7A929EQ38239229-0805C978-6082-43EA-8B19-BA2250FFE45AQ38719594-4627D9D7-6759-4105-BD40-86A1E3AB524FQ39029976-06D8D3E4-C2C6-4532-A37D-6D0FBAD5C195Q39450576-A676F31D-34BC-484C-BD9F-3EE2E47C5FB3Q40776672-BA01ACAD-8C2F-4B86-9356-3CA227F9AF5DQ40819992-5D9523AB-AD95-49DA-913F-E225EF5A3C7CQ41251561-883BBA61-A090-400E-9106-4EDAEFB9F32AQ41587899-E80AD349-0C5B-45F0-B9B6-1F9D0C3F73BEQ47438629-89BC5D25-6D50-40B2-876A-165F529C6C92Q54287597-6065A693-4A3B-4F56-8995-277FFED61C9C
P2860
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular genetics of medullar ...... for novel therapeutic targets.
@en
Molecular genetics of medullar ...... for novel therapeutic targets.
@nl
type
label
Molecular genetics of medullar ...... for novel therapeutic targets.
@en
Molecular genetics of medullar ...... for novel therapeutic targets.
@nl
prefLabel
Molecular genetics of medullar ...... for novel therapeutic targets.
@en
Molecular genetics of medullar ...... for novel therapeutic targets.
@nl
P356
P1476
Molecular genetics of medullar ...... for novel therapeutic targets
@en
P2093
Aniello Cerrato
Massimo Santoro
P304
P356
10.1677/JME-09-0024
P577
2009-04-21T00:00:00Z